1. Home
  2. NHIC vs AVR Comparison

NHIC vs AVR Comparison

Compare NHIC & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHIC
  • AVR
  • Stock Information
  • Founded
  • NHIC 2024
  • AVR 1999
  • Country
  • NHIC United States
  • AVR Australia
  • Employees
  • NHIC N/A
  • AVR N/A
  • Industry
  • NHIC
  • AVR
  • Sector
  • NHIC
  • AVR
  • Exchange
  • NHIC NYSE
  • AVR NYSE
  • Market Cap
  • NHIC 276.7M
  • AVR 241.5M
  • IPO Year
  • NHIC 2025
  • AVR 2024
  • Fundamental
  • Price
  • NHIC $10.04
  • AVR $4.63
  • Analyst Decision
  • NHIC
  • AVR Strong Buy
  • Analyst Count
  • NHIC 0
  • AVR 4
  • Target Price
  • NHIC N/A
  • AVR $16.50
  • AVG Volume (30 Days)
  • NHIC 3.3K
  • AVR 146.7K
  • Earning Date
  • NHIC 01-01-0001
  • AVR 05-13-2025
  • Dividend Yield
  • NHIC N/A
  • AVR N/A
  • EPS Growth
  • NHIC N/A
  • AVR N/A
  • EPS
  • NHIC N/A
  • AVR N/A
  • Revenue
  • NHIC N/A
  • AVR $2,493,000.00
  • Revenue This Year
  • NHIC N/A
  • AVR $29.52
  • Revenue Next Year
  • NHIC N/A
  • AVR $204.83
  • P/E Ratio
  • NHIC N/A
  • AVR N/A
  • Revenue Growth
  • NHIC N/A
  • AVR N/A
  • 52 Week Low
  • NHIC $10.02
  • AVR $2.34
  • 52 Week High
  • NHIC $10.22
  • AVR $8.79
  • Technical
  • Relative Strength Index (RSI)
  • NHIC N/A
  • AVR N/A
  • Support Level
  • NHIC N/A
  • AVR N/A
  • Resistance Level
  • NHIC N/A
  • AVR N/A
  • Average True Range (ATR)
  • NHIC 0.00
  • AVR 0.00
  • MACD
  • NHIC 0.00
  • AVR 0.00
  • Stochastic Oscillator
  • NHIC 0.00
  • AVR 0.00

About NHIC NEWHOLD INVESTMENT CORP III

NewHold Investment Corp III is a blank check company.

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Share on Social Networks: